Home > Research > Publications & Outputs > Physician reported sputum colour measured by th...
View graph of relations

Physician reported sputum colour measured by the acute bronchitis symptoms scale (ABSS) in the MOSAIC study is indepedent of other symptoms of chronic and acute bronchitis.

Research output: Contribution to Journal/MagazineSpecial issuepeer-review

Published

Standard

Physician reported sputum colour measured by the acute bronchitis symptoms scale (ABSS) in the MOSAIC study is indepedent of other symptoms of chronic and acute bronchitis. / Spencer, Sally; Sagnier, Pierre-Phillipe; Jones, Paul W.
In: American Journal of Respiratory and Critical Care Medicine, Vol. 169, 2004, p. A768.

Research output: Contribution to Journal/MagazineSpecial issuepeer-review

Harvard

APA

Vancouver

Author

Spencer, Sally ; Sagnier, Pierre-Phillipe ; Jones, Paul W. / Physician reported sputum colour measured by the acute bronchitis symptoms scale (ABSS) in the MOSAIC study is indepedent of other symptoms of chronic and acute bronchitis. In: American Journal of Respiratory and Critical Care Medicine. 2004 ; Vol. 169. pp. A768.

Bibtex

@article{73568756572a4c9cb03b7fa915b4cf94,
title = "Physician reported sputum colour measured by the acute bronchitis symptoms scale (ABSS) in the MOSAIC study is indepedent of other symptoms of chronic and acute bronchitis.",
abstract = "BackgroundThe onset of an acute exacerbation of COPD is defined by an acute worsening of symptoms over a period of approximately 7 days (Pauwels et al, ERS, 2003, P1588). We examined the change in symptoms from the chronic to acute phase of bronchitis for their sensitivity to the development of an exacerbation.MethodA total of 730 patients (FEV1 46 sd 19 % pred) were administered the 7-item ABSS questionnaire in stable state and subsequently during an acute infective exacerbation. Consistency of the 5 severity-graded responses to each of the 7 items were examined using Rasch analysis. Significant differences between observed item responses and the Guttman-scaling expectations of the Rasch model are tabulated. A p value <0.05 indicates that an items responses do not fit with the responses to other items. [Table]Responses to sputum colour had good scaling properties during an acute infective epsiode but not when stable. Change in colour of phlegm score between chronic and acute phase of bronchitis was greater than change in the other 6 items (p<0.0001).ConclusionsColour of sputum is independent of other symptoms of bronchitis in both the stable and acute phases of chronic bronchitis. This item has good scaling properties and may represent a marker of an exacerbation whilst other symptoms reflect changes in severity along a continuous scale.",
author = "Sally Spencer and Pierre-Phillipe Sagnier and Jones, {Paul W}",
year = "2004",
language = "English",
volume = "169",
pages = "A768",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "AMER THORACIC SOC",

}

RIS

TY - JOUR

T1 - Physician reported sputum colour measured by the acute bronchitis symptoms scale (ABSS) in the MOSAIC study is indepedent of other symptoms of chronic and acute bronchitis.

AU - Spencer, Sally

AU - Sagnier, Pierre-Phillipe

AU - Jones, Paul W

PY - 2004

Y1 - 2004

N2 - BackgroundThe onset of an acute exacerbation of COPD is defined by an acute worsening of symptoms over a period of approximately 7 days (Pauwels et al, ERS, 2003, P1588). We examined the change in symptoms from the chronic to acute phase of bronchitis for their sensitivity to the development of an exacerbation.MethodA total of 730 patients (FEV1 46 sd 19 % pred) were administered the 7-item ABSS questionnaire in stable state and subsequently during an acute infective exacerbation. Consistency of the 5 severity-graded responses to each of the 7 items were examined using Rasch analysis. Significant differences between observed item responses and the Guttman-scaling expectations of the Rasch model are tabulated. A p value <0.05 indicates that an items responses do not fit with the responses to other items. [Table]Responses to sputum colour had good scaling properties during an acute infective epsiode but not when stable. Change in colour of phlegm score between chronic and acute phase of bronchitis was greater than change in the other 6 items (p<0.0001).ConclusionsColour of sputum is independent of other symptoms of bronchitis in both the stable and acute phases of chronic bronchitis. This item has good scaling properties and may represent a marker of an exacerbation whilst other symptoms reflect changes in severity along a continuous scale.

AB - BackgroundThe onset of an acute exacerbation of COPD is defined by an acute worsening of symptoms over a period of approximately 7 days (Pauwels et al, ERS, 2003, P1588). We examined the change in symptoms from the chronic to acute phase of bronchitis for their sensitivity to the development of an exacerbation.MethodA total of 730 patients (FEV1 46 sd 19 % pred) were administered the 7-item ABSS questionnaire in stable state and subsequently during an acute infective exacerbation. Consistency of the 5 severity-graded responses to each of the 7 items were examined using Rasch analysis. Significant differences between observed item responses and the Guttman-scaling expectations of the Rasch model are tabulated. A p value <0.05 indicates that an items responses do not fit with the responses to other items. [Table]Responses to sputum colour had good scaling properties during an acute infective epsiode but not when stable. Change in colour of phlegm score between chronic and acute phase of bronchitis was greater than change in the other 6 items (p<0.0001).ConclusionsColour of sputum is independent of other symptoms of bronchitis in both the stable and acute phases of chronic bronchitis. This item has good scaling properties and may represent a marker of an exacerbation whilst other symptoms reflect changes in severity along a continuous scale.

M3 - Special issue

VL - 169

SP - A768

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

ER -